ALCYONE THERAPEUTICS

alcyone-therapeutics-logo

Alcyone Therapeutics is Pioneering Next-Generation Precision CNS Genetic Therapies to unlock new possibilities and overcome challenges for CNS therapy development.

#SimilarOrganizations #People #Financial #Website #More

ALCYONE THERAPEUTICS

Social Links:

Industry:
Biotechnology Therapeutics

Founded:
2010-01-01

Address:
Lowell, Massachusetts, United States

Country:
United States

Website Url:
http://www.alcyonetx.com

Total Employee:
11+

Status:
Active

Contact:
(978) 709-1946

Email Addresses:
[email protected]

Total Funding:
23 M USD

Technology used in webpage:
Euro CrUX Top 50m CrUX Dataset


Similar Organizations

aclaris-therapeutics-logo

Aclaris Therapeutics

Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.

alia-therapeutics-logo

Alia Therapeutics

Alia Therapeutics is developing next-generation gene-editing medicines to cure rare genetic diseases.

jounce-therapeutics-logo

Jounce Therapeutics

Jounce Therapeutics is developing cancer immune-therapies to harness the immune system to attack cancerous cells and tumors.

proteostasis-therapeutics-logo

Proteostasis Therapeutics

Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.

semma-therapeutics-logo

Semma Therapeutics

Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.

slingshot-biosciences-logo

Slingshot Biosciences

Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.


Current Advisors List

david-donabedian-phd_image

David Donabedian, PhD Board Member @ Alcyone Therapeutics
Board_member
2012-02-01

Current Employees Featured

david-donabedian-phd_image

David Donabedian, PhD
David Donabedian, PhD Founder @ Alcyone Therapeutics
Founder
2012-02-01

deep-singh_image

Deep Singh
Deep Singh Head of R&D, Precision Delivery @ Alcyone Therapeutics
Head of R&D, Precision Delivery

pj-anand_image

PJ Anand
PJ Anand President and CEO @ Alcyone Therapeutics
President and CEO
2021-01-01

Founder


david-donabedian-phd_image

David Donabedian, PhD

pj-anand_image

PJ Anand

Investors List

rtw-investments-llc_image

RTW Investments

RTW Investments investment in Venture Round - Alcyone Therapeutics

Official Site Inspections

http://www.alcyonetx.com

  • Host name: 42.182.139.34.bc.googleusercontent.com
  • IP address: 34.139.182.42
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Alcyone Therapeutics"

Our Company - Alcyone Tx

Alcyone was established in 2012 on the premise that better dosing & delivery is needed to effectively treat complex neurological disorders. Alcyone built a team to overcome this โ€ฆSee details»

Alcyone Therapeutics - Crunchbase Company Profile

Organization. Alcyone Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. โ€ฆSee details»

Contact - Alcyone Tx

Alcyone Therapeutics, Inc. 116 John Street, Suite 300 Lowell, MA 01852 USA +1 978.709.1946See details»

Alcyone Lifesciences - Overview, News & Similar companies

Alcyone Lifesciences contact info: Phone number: (978) 709-1946 Website: www.alcyonetx.com What does Alcyone Lifesciences do? Alcyone Therapeutics is a biotechnology company โ€ฆSee details»

Alcyone Therapeutics - LifeScienceHistory.com

Alcyonetx.com. 116 John St Suite 300. Lowell, MA 1852. Company Info Phone (978) 709-1946 Year Established 2012. Contacts PJ Anand Founder, President & CEO Deep Singh VP & โ€ฆSee details»

Alcyone Therapeutics - VentureRadar

Website: https://alcyonetx.com/ Pioneers next-generation CNS precision gene-based therapeutics for complex neurological conditions, integrating innovation in ...See details»

Alcyone Therapeutics, Inc - CAGE.report

Alcyonetx.com. E-Commerce Website: Contact Person: Bryn Martin County Code (3 digit): 017 Congressional District: 03 Metropolitan Statistical Area: 4560 CAGE Code: ... Organization, โ€ฆSee details»

Careers - Alcyone Tx

An organization that has a diverse employee population including diversity in thought and in background is a company poised to succeed. That is why we are committed to fostering a culture that values and celebrates diversity, equity โ€ฆSee details»

Alcyone Therapeutics Inc. - LinkedIn

Alcyone Therapeutics Inc. Biotechnology Research Lowell, MA 3,023 followers Alcyone is pioneering next-generation intra-CSF (cerebrospinal fluid) CNS precision gene-based therapiesSee details»

Alcyone Therapeutics - PitchBook

Alcyone Therapeutics General Information Description. Developer of neural intervention technology designed to treat neurological conditions. The company's technology is based on โ€ฆSee details»

Alcyone Lifesciences: Employee Directory | ZoomInfo.com

Alcyone Lifesciences Contact Info: Phone number: (978) 709-1946 Website: www.alcyonetx.com What does Alcyone Lifesciences do? Alcyone Therapeutics is a biotechnology company โ€ฆSee details»

Alcyone Therapeutics Inc. (@AlcyoneTx) - Twitter

Dec 3, 2021 The latest Tweets from Alcyone Therapeutics Inc. (@AlcyoneTx): "Bryn Martin, VP of Research, Drug Delivery and CSF Sciences, will be at the 3rd Annual #GeneTherapy ...See details»

Alcyone Therapeutics Inc. Company Overview, Contact Details ...

Jun 9, 2021 Alcyone Therapeutics hired Norbert Riedel as Chief Scientific Officer and Head of research & development on May 8th '24. Alcyone Therapeutics, a clinical-stage biotechnology โ€ฆSee details»

Alcyone Therapeutics Strengthens Executive Team with New โ€ฆ

LOWELL, Mass., Oct. 25, 2021 โ€“ Alcyone Therapeutics (โ€œAlcyoneโ€), a biotechnology company developing precision therapies for neurological disorders with high unmet medical needs, โ€ฆSee details»

Alcyone Presents Preclinical Data on Gene Therapy Programs with โ€ฆ

May 18, 2022 For more information, visit www.alcyonetx.com. About Alcyone's Strategic Collaboration with the Abigail Wexner Research Institute at Nationwide Children's HospitalSee details»

Company News Archive - Alcyone Tx

Jul 31, 2024 Dr. Riedel holds a Ph.D. and a Diploma in Biochemistry from the University of Frankfurt and serves on the boards of Jazz Pharmaceuticals, Eton Pharmaceuticals, and the โ€ฆSee details»

Alcyone Announces Two Oral Presentations on its Gene Therapy โ€ฆ

May 2, 2022 For more information, visit www.alcyonetx.com. About Alcyone's Strategic Collaboration with the Abigail Wexner Research Institute at Nationwide Children's HospitalSee details»

Alcyone Therapeutics Announces Continued Enrollment Approval โ€ฆ

Jul 31, 2024 Alcyone's ThecaFlex is an implantable medical device under investigation for routine subcutaneous administration of therapeutics to the cerebrospinal fluid (CSF).See details»

Pipeline - Alcyone Tx

Our streamlined approach facilitates application of technical and disease-area expertise for rapid progression of therapies to the clinic.See details»

linkstock.net © 2022. All rights reserved